Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C1RL |
| Upstream (Parents) |
|---|
| (<<) CFH → C1RL |
| (<<) PLGLB1///PLGLB2 → C1RL |
| (<<) CD302 → C1RL |
| Downstream (Children) |
|---|
| C1RL → RORA (>>) |
| C1RL → MOCS1 (>>) |
| C1RL → GABARAPL3///GABARAPL1 (>>) |
| C1RL → CD320 (>>) |
| C1RL → TNFSF10 (>>) |
| C1RL → KAT2B (>>) |
| C1RL → ACO1 (>>) |
| C1RL → GABARAPL1 (>>) |
| C1RL → IL6ST (>>) |
| C1RL → CROT (>>) |
| C1RL → RAB27A (>>) |
| C1RL → C11orf49 (>>) |
| C1RL → ALDOA (>>) |
| C1RL → TFRC (>>) |
| C1RL → ACADM (>>) |
| C1RL → CTBS (>>) |
| C1RL → CSAD (>>) |
| C1RL → GREM2 (>>) |
| C1RL → SHBG (>>) |
| C1RL → CHAD (>>) |
| C1RL → SOX5 (>>) |
| C1RL → CYP7B1 (>>) |
| C1RL → MPPED1 (>>) |
| C1RL → TSHZ2 (>>) |
| C1RL → ERO1LB (>>) |
| C1RL → MAN1A1 (>>) |
| C1RL → F8 (>>) |
| C1RL → IMPDH2 (>>) |
| C1RL → NAMPT (>>) |
| C1RL → ACOT1///ACOT2 (>>) |
| C1RL → FECH (>>) |
| C1RL → MCC (>>) |
